series-b
Stage
1
Investors
About
Vitara Biomedical is developing EXTEND, an investigational neonatal support system that immerses extremely premature newborns in a fluid-filled environment for up to 28 days to support lung and organ development and bridge them to conventional NICU care.
Explore Vitara Biomedical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.